Hepaglan 25000IU Injection

PRODUCT INTRODUCTION

Hepaglan 25000IU Injection is a medical product that contains Hepatitis B Immunoglobulin (HBIG) as its active ingredient. It is primarily used as a prophylactic treatment to prevent the onset of hepatitis B infection. This injection is a highly purified solution of human antibodies, designed to provide passive immunity against the hepatitis B virus (HBV). The immune globulin in Hepaglan helps the body to resist infections caused by HBV, particularly in individuals who are at high risk of exposure to the virus, such as newborns born to mothers with hepatitis B or patients undergoing liver transplants.

The product is typically administered via intramuscular or intravenous injection, and its formulation is designed to provide rapid immunity in individuals exposed to HBV, either post-exposure or as part of a preventive regimen in certain high-risk medical procedures. The injection comes in a vial containing a specific dosage of 25,000 IU (International Units), providing an adequate concentration of antibodies needed for protection.

USES OF HEPAGLAN 25000IU INJECTION

Hepaglan 25000IU Injection is mainly used for two key purposes:

Post-Exposure Prophylaxis (PEP)

It is used in post-exposure settings where an individual has been exposed to the hepatitis B virus (HBV). This may occur through needle-stick injuries, blood transfusions, sexual exposure, or from an infected mother to her newborn. The injection is administered as an immediate post-exposure measure to reduce the likelihood of the virus establishing an infection.

Prevention in High-Risk Individuals

Hepaglan 25000IU Injection is also used for prophylaxis in high-risk individuals. For example, infants born to mothers who are chronic carriers of the hepatitis B virus are given the injection shortly after birth. This is crucial in preventing neonatal hepatitis B infection, which could otherwise lead to chronic hepatitis, liver cirrhosis, and liver cancer later in life.

It may also be used in individuals undergoing liver transplantation who are at increased risk of HBV infection, ensuring that the immune system is sufficiently protected during the recovery period.

BENEFITS OF HEPAGLAN 25000IU INJECTION

The primary benefit of Hepaglan 25000IU Injection is its ability to provide immediate and effective passive immunity against hepatitis B. The following are the key advantages of the product:

a. Prevention of Hepatitis B Infection

By introducing pre-formed antibodies into the body, Hepaglan ensures rapid immunity against the hepatitis B virus, thereby preventing the onset of HBV infection. This is particularly beneficial in individuals who have been exposed to the virus and need quick intervention to avoid infection.

b. Effective for High-Risk Newborns

Infants born to mothers with hepatitis B are at a significant risk of contracting the virus, which can lead to chronic liver conditions. Hepaglan 25000IU Injection significantly reduces the risk of transmission of hepatitis B from mother to child.

c. Support for Immunocompromised Individuals

For patients with compromised immune systems, such as those undergoing organ transplants or receiving chemotherapy, Hepaglan provides an added layer of protection against infections, ensuring that they do not succumb to HBV due to lowered immunity.

d. Used Along with Other Vaccines

In some cases, Hepaglan 25000IU Injection is used in conjunction with the hepatitis B vaccine to ensure full protection against HBV in high-risk individuals. While the vaccine triggers the body to produce its own antibodies, Hepaglan provides immediate passive immunity until the body can generate sufficient levels of antibodies.

SIDE EFFECTS OF HEPAGLAN 25000IU INJECTION

Although Hepaglan 25000IU Injection is generally well-tolerated, like all medical treatments, it can cause side effects. The most common side effects include:

a. Pain at the Injection Site

Mild to moderate pain, redness, or swelling at the injection site is common after administration. This is typically temporary and resolves within a few hours to a day.

b. Allergic Reactions

Some individuals may experience allergic reactions, ranging from mild rashes to more severe symptoms such as itching, hives, or shortness of breath. Anaphylaxis, though rare, can occur in individuals who have a hypersensitivity to immunoglobulin preparations.

c. Fever

A mild fever may develop in some patients following the injection. This is typically short-lived and does not require medical attention.

d. Headache or Fatigue

Some individuals may experience headaches or general fatigue after the injection. These side effects are usually temporary and resolve on their own within a few days.

e. Nausea

Occasionally, individuals may feel nauseous or experience mild gastrointestinal discomfort after receiving the injection.

f. Chills or Body Aches

In rare instances, some patients may experience chills or body aches, which typically subside within a few hours.

FAQ

Q1. How soon does Hepaglan 25000IU Injection provide protection after administration? A1. Hepaglan 25000IU Injection provides immediate passive immunity, typically within hours after administration. However, it is important to follow the recommended dosage schedule for continued protection, especially in cases where the injection is part of a post-exposure prophylaxis protocol.

Q2. Is Hepaglan 25000IU Injection safe for pregnant women? A2. Hepaglan 25000IU Injection is generally considered safe for use during pregnancy, especially when the potential benefits outweigh the risks. However, it should only be used under the supervision of a healthcare provider.

Q3. Can Hepaglan 25000IU Injection be used in children? A3. Yes, Hepaglan 25000IU Injection is commonly used in newborns and children, especially those born to mothers who are hepatitis B carriers. The dosage and frequency of administration will depend on the specific medical circumstances.

Q4. Are there any long-term side effects associated with Hepaglan 25000IU Injection? A4. Long-term side effects are rare. However, any adverse reactions should be reported to a healthcare provider. Most side effects are short-term and resolve without intervention.

Q5. Can Hepaglan 25000IU Injection be used as a sole treatment for hepatitis B infection? A5. Hepaglan 25000IU Injection is not intended to treat an active hepatitis B infection but to provide passive immunity for prevention. If you have an active infection, antiviral medications are necessary for treatment.

Q6. What should I do if I miss a dose of Hepaglan 25000IU Injection? A6. If you miss a dose of Hepaglan 25000IU Injection, contact your healthcare provider immediately for guidance on rescheduling the administration. Timing is crucial for preventing hepatitis B infection.

Q7. Can Hepaglan 25000IU Injection be administered alongside other vaccinations? A7. Yes, Hepaglan can be administered alongside other vaccinations, including the hepatitis B vaccine, to provide comprehensive protection against hepatitis B. Your healthcare provider will determine the most suitable schedule for administering the injection and vaccinations.

Disclaimer

Singhla Medicos primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Singhla Medicos. Our mission is to support, not replace, the doctor-patient relationship.